Out-licensing opportunities
Vernalis invites expressions of interest for the following candidates. Please click on the table for detailed information.
| Product | Indication | Late Research | Pre-Clinical | Phase I | Phase II | Phase III | Marketed | Marketing Rights | Peak Sales |
| V85546 | Inflammatory Disease | ![]() |
![]() |
![]() |
Worldwide | $$ |
Latest News
Wednesday, 02 May 2012
Successful Outcome for V81444 in Phase I Study
Vernalis today announces the successful outcome of its Phase I trial of V81444


